Dr. Agarwals Health Care Ltd has received unanimous approval from its unsecured creditors for a Scheme of Amalgamation with Dr. Agarwal's Eye Hospital Limited. This crucial step moves the merger process forward, subject to final NCLT sanction.
Dr. Agarwals Health Care Ltd Creditors Unanimously Approve Merger Scheme
Dr. Agarwals Health Care Ltd received unanimous approval from its unsecured creditors for the proposed Scheme of Amalgamation with Dr. Agarwal's Eye Hospital Limited on July 02, 2026. The meeting was convened as per the directive of the Hon'ble National Company Law Tribunal (NCLT).
Reader Takeaway: Unanimous creditor approval reduces merger execution risk; final NCLT sanction is the next key hurdle.
What just happened
An important procedural step in the amalgamation of Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited has been completed. Unsecured creditors met on July 02, 2026, to vote on the Scheme of Amalgamation. The resolution to approve the scheme was passed with 100% support from all participating creditors.
Why this matters
This unanimous approval from unsecured creditors is a significant positive development. It signifies that a major stakeholder group has agreed to the terms of the merger, reducing potential roadblocks and de-risking the execution of the amalgamation. It demonstrates progress in the legal and procedural aspects of the merger.
The backstory
The amalgamation process is being conducted under Sections 230-232 of the Companies Act, 2013. The National Company Law Tribunal (NCLT) had previously ordered the convening of this creditors' meeting via an order dated May 05, 2026. Mr. Shivam Parashar was appointed as the Scrutinizer for the voting process.
What changes now
With the unsecured creditors' vote secured, Dr. Agarwals Health Care Limited has fulfilled a key requirement for the amalgamation. The board is now empowered to proceed with implementing the approved scheme and addressing any related matters. The company is now awaiting the final sanction from the NCLT to complete the merger.
Risks to watch
The primary remaining risk is the final approval from the NCLT. Any unforeseen delays or conditions imposed by the tribunal could impact the timeline and success of the amalgamation.
Context metrics (time-bound)
- Creditor Meeting Date: July 02, 2026
- NCLT Order Date: May 05, 2026
- Voting Results: 100% in favor from 32 participating members and 11,10,20,428 votes.
What to track next
Investors should monitor future filings for the announcement of the final NCLT order approving the Scheme of Amalgamation. This will mark the completion of the merger process.